Anti-ERCC1, Mouse-Mono(8F1)

• 商品コード：NB500-704SS
• メーカー：NOV
• 包装：0.025ml
• 価格： ¥41,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Lee S et al. Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamou
  Lee S et al
  2010/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 2
• 文献情報：
  Bepler G et al. Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. J. Clin. Oncol. 2013 Jul;31(19):2404-12
  Bepler G et al
  2013/01/01
  
• 備考：
  Species: Human, Applications: IHC-P
• 参照：
  

• No.： 3
• 文献情報：
  Soltermann A et al. Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10. J Clin Bioinforma 2011;1:25
  Soltermann A et al
  2011/01/01
  
• 備考：
  Applications:
• 参照：
  

• No.： 4
• 文献情報：
  Bepler G et al. A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701). Cancer 2014 Aug;120(15):2343-51
  Bepler G et al
  2014/01/01
  
• 備考：
  Species: Human, Applications: IHC-P
• 参照：
  

• No.： 5
• 文献情報：
  Al-Minawi AZ et al. The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells. Nucleic Acids Res. 2008 Jan;36(1):1-9
  Al-Minawi AZ et al
  2008/01/01
  
• 備考：
  Species: Human, Chinese Hamster, Applications: WB
• 参照：
  

• No.： 6
• 文献情報：
  Hwang IG et al. ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy. Cancer 2008 Sep;113(6):1379-86
  Hwang IG et al
  2008/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 7
• 文献情報：
  Ozcan MF et al. Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol. Oncol. 2012 Aug;
  Ozcan MF et al
  2012/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 8
• 文献情報：
  Azim HA et al. ERCC1 Expression in Diffuse Large B-Cell Lymphoma Patients Treated with a Cisplatin-Based Regimen : A Brief Communication. J Egypt Natl Canc Inst 2007 Sep;19(3):176-7
  Azim HA et al
  2007/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 9
• 文献情報：
  Besse B et al. ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy. Ann. Oncol. 2011 Mar;22(3):575-81
  Besse B et al
  2011/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 10
• 文献情報：
  Jun HJ et al. ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br. J. Cancer 2008 Jul;99(1):167-72
  Jun HJ et al
  2008/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 11
• 文献情報：
  Sodja E et al. Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy. Eur J Cancer 2012 Jul;
  Sodja E et al
  2012/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 12
• 文献情報：
  Shao YY et al. Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin. Jpn. J. Clin. Oncol. 2010 Apr;40(4):286-93
  Shao YY et al
  2010/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 13
• 文献情報：
  Kim MK et al. Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy. Clin. Cancer Res. 2008 Jul;14(13):4225-31
  Kim MK et al
  2008/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 14
• 文献情報：
  Bhagwat NR et al. Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res. 2009 Sep;69(17):6831-8
  Bhagwat NR et al
  2009/01/01
  
• 備考：
  Species: Human, Applications: IHC, WB
• 参照：
  

• No.： 15
• 文献情報：
  Su CH et al. Gemcitabine causes telomere attrition by stabilizing TRF2. Eur J Cancer 2012 Jun;
  Su CH et al
  2012/01/01
  
• 備考：
  Species: Human, Applications: WB
• 参照：